Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 3/20 | 0.54 |
| ▸ | CA2 | P00918 | 3/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 11/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23137986 | 0.87 | SIGMAR1 (0.53) | SIGMAR1CA2EPHX1EPHX2 | |
| SCHEMBL5197128 | 0.86 | EPHX1 (0.56) | SIGMAR1EPHX1EPHX2SMN1; SMN2KDM4E | |
| SCHEMBL23137868 | 0.86 | SMN1; SMN2 (0.55) | SIGMAR1EPHX1EPHX2SMN1; SMN2KDM4E | |
| SCHEMBL18896234 | 0.85 | SIGMAR1 (0.51) | SIGMAR1CA1CA2EPHX1EPHX2 | |
| SCHEMBL23137682 | 0.85 | EPHX1 (0.54) | SIGMAR1EPHX1EPHX2SMN1; SMN2 | |
| SCHEMBL5152348 | 0.85 | CA2 (0.56) | SIGMAR1CA1CA2SMN1; SMN2ALDH1A1 | |
| SCHEMBL21695556 | 0.85 | SMN1; SMN2 (0.53) | SIGMAR1CA1CA2EPHX1SMN1; SMN2 | |
| SCHEMBL19019059 | 0.84 | EPHX1 (0.54) | SIGMAR1EPHX1EPHX2SMN1; SMN2 | |
| SCHEMBL10597660 | 0.84 | KMT2A (0.53) | SIGMAR1CA1CA2SMN1; SMN2ALDH1A1 | |
| SCHEMBL24021247 | 0.84 | EPHX1 (0.54) | SIGMAR1CA1CA2EPHX1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088935-B2 | Compounds and methods for the treatment of asthma | IRONWOOD PHARMACEUTICALS, INC. (US) | 2012-01-03 | — | — | US | disclosed |